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Abstract
Basal cell carcinoma (BCC) is the commonest tumor in human. About 70% sporadic BCCs
bear somatic mutations in the PATCHED1 tumor suppressor gene which encodes the recep-
tor for the Sonic Hedgehogmorphogen (SHH). PATCHED1 germinal mutations are associ-
ated with the dominant Nevoid Basal Cell Carcinoma Syndrome (NBCCS), a major hallmark
of which is a high susceptibility to BCCs. Although the vast majority of sporadic BCCs arises
exclusively in sun exposed skin areas, 40 to 50% BCCs from NBCCS patients develop in non
photo-exposed skin. Since overwhelming evidences indicate that microenvironment may
both bemodified by- and influence the- epithelial tumor, we hypothesized that NBCCS fibro-
blasts could contribute to BCCs in NBCCS patients, notably those developing in non photo-
exposed skin areas. The functional impact of NBCCS fibroblasts was then assessed in orga-
notypic skin cultures with control keratinocytes. Onset of epidermal differentiation was
delayed in the presence of primary NBCCS fibroblasts. Unexpectedly, keratinocyte prolifera-
tion was severely reduced and showed high levels of nuclear P53 in both organotypic skin
cultures and in fibroblast-led conditioning experiments. However, in spite of increased levels
of senescence associated β-galactosidase activity in keratinocytes cultured in the presence
of medium conditioned by NBCCS fibroblasts, we failed to observe activation of P16 and P21
and then of bona fide features of senescence. Constitutive extinction of P53 inWT keratino-
cytes resulted in an invasive phenotype in the presence of NBCCS fibroblasts. Finally, we
found that expression of SHHwas limited to fibroblasts but was dependent on the presence
of keratinocytes. Inhibition of SHH binding resulted in improved epidermal morphogenesis.
Altogether, these data suggest that the repertoire of diffusible factors (including SHH)
expressed by primary NBCCS fibroblasts generate a stress affecting keratinocytes behavior
and epidermal homeostasis. Our findings suggest that defects in dermo/epidermal interac-
tions could contribute to BCC susceptibility in NBCCS patients.
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Introduction
In the human, most sporadic cancers are from epithelial origin and are thought to arise follow-
ing sequences of genotoxic injuries [1]. The vast majority of cancers affecting the general popu-
lation (about 30%) derive from skin, notably from the epidermal compartment. The ultraviolet
(UV) content of the sunlight is by far the most frequent etiological factor in cutaneous carcino-
genesis; in this context, exposure to sunlight is responsible for basal- (BCC), and squamous-
cell carcinoma (SCC) as well as malignant melanoma (MM) [2]. Patients suffering from the
dominantly inherited disease Nevoid Basal Cell Carcinoma/Gorlin-Goltz Syndrome (NBCCS)
[3] express a variety of traits including developmental failures such as polysyndactily, bifid ribs,
odontogenic keratocysts, as well as proneness toward medulloblastoma and ovarian cancers.
However, the most severe genetic affliction in NBCCS patients is by far their constitutive sus-
ceptibility toward BCCs [3, 4, 5]. For yet unexplained reasons, 40 to 50% of those NBCCS
BCCs, develop in non photo-exposed skin areas, [6] suggesting that susceptibility toward BCCs
is not linked to inappropriate responses to DNA damages such as observed in the xeroderma
pigmentosum nucleotide excision repair genetic syndrome [7].
Germinal mutations responsible for the NBCCS encompass the PATCHED1 (PTCH1)
tumor suppressor gene, most of which are non-sense and are thought to be deleterious. No evi-
dence of a clear genotype-phenotype relationship has yet been put forward. PATCHED is a
putative 12-pass trans-membrane receptor that binds the diffusible morphogen molecule
SONIC HEDGEHOG (SHH) [8–10]. In brief, control of the pathway depends on the absence
or the presence of SHH. In the absence of SHH, PATCHED acts as a repressor leading to inac-
tivation of the GLI transcriptional activators. Upon receipt of the SHH signal, active forms of
GLI transcriptional factors are produced to modulate the expression of SHH target genes [11].
In more than 50% sporadic BCCs, somatic mutations in the PATCHED1 gene have also
been identified, with frequent loss of heterozygosity including the PATCHED1 locus [12].
However, since virtually 100% sporadic BCCs exhibited accumulation of GLImRNAs, [13] it
has been proposed that constitutive de-repression of the SHH/PATCHED pathway could
result in inappropriate control of the cell proliferation and differentiation balance, develop-
mental failures and cancer development, most notably BCCs [11].
In sporadic cancers, overwhelming evidences have accumulated indicating that the micro-
environment of epithelial cells could play a decisive role in the onset, growth, and fate of neo-
plastic cells. Cancer cells can activate their microenvironment, leading to remodeling of
components of the extracellular matrix and tumor cell growth through de novo secretion of
various cytokines and growth factors [14]. In animal models, the tumor microenvironment has
also been shown to generate oxidative damages and genetic instability, hence promoting inva-
sive capacity of epithelial cells [15].
Based on the fact that sun exposure is not an essential etiological factor of NBCCS BCCs, [16]
we investigated whether altered dermo-epidermal interactions may play a role in BCCs predispo-
sition of NBCCS patients. More specifically, as the SHH/PATCHED pathway is known to be
involved in intercellular control of proliferation, we hypothesized that deregulation of the SHH/
PATCHED pathway in mesenchymal cells may affect proper control of epithelial cell growth and
contributes to the expression of microenvironmental factors leading to the development of
BCCs. In this respect, our previous transcriptome analyses of primary NBCCS fibroblasts cul-
tured in 3D organotypic systems, revealed their significant inclination to express a phenotype
closely resembling that of fibroblasts associated to sporadic BCCs [17, 18]. The most significant
differential expression between wild type (WT) and NBCCS fibroblasts concerns proteins
involved in the composition of the extracellular matrix and its remodeling, cellular proliferation,
invasion, angiogenesis, and control of the production of reactive oxygen species (ROS).
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In the present study, we aimed at better understanding the fact that NBCCS patients develop
BCCs in skin areas preserved from apparent genotoxic insults. We took into account that
mesodermal-ectodermal interactions play a major role upon development, maintenance and
repair of adult organs as well as cancer development [19]. Our results indicate that the presence
of PATCHED1 +/- NBCCS fibroblasts in the dermal compartment of organotypic skin cultures
(OSC) is sufficient for severely perturb epidermal differentiation, proliferation, and cell cycle
control in the overlaying WT epidermis. These perturbations, however, did not correlate with
expression of bona fidemarkers of apoptosis or senescence. Altogether, the present data
strongly suggest for the first time that the dermal microenvironment led by NBCCS fibroblasts
may play a functional role in high levels of BCCs in NBCCS patients in absence of external gen-
otoxic stress.
Materials and Methods
This study was approved by a local French ethic committee (Commité consultatif pour la pro-
tection des personnes en recherche biomédicale, CCPPRB: CSET935) and was conducted after
informed written consent of NBCCS patients.
Skin biopsies and primary cell cultures
Human primary fibroblasts and keratinocytes were isolated from healthy, non photo-exposed
skin biopsies of either control individuals or NBCCS patients bearing either nonsense or mis-
sense mutations in the PATCHED1 gene (S1 Table).
Primary dermal fibroblasts were grown in DMEM supplemented with 10% fetal calf serum
(FCS), 2 mM glutamine, 1% penicillin/streptomycin, 1 mM sodium pyruvate, 1% non essential
amino acids, and 0.2% fungizone, at 37°C, 5% CO2. Fibroblasts strains (passages P6 to P9)
were seeded at 104 cells/cm², and cultured up to 80–90% confluence before processing. Under
standard conditions, primary keratinocytes, E6-E7-immortalized keratinocytes, and SCC13
cell line were cultured on feeder layers of lethally irradiated 3T3-J2 Swiss mouse fibroblasts in
cFAD keratinocyte medium [20]. When indicated, cFAD was replaced by a FADmedium con-
taining 0.5% FCS. Immortalization of keratinocytes was performed using the pLXSN16E6-E7
retroviral vector [21] and Phoenix helper cells (http://www.stanford.edu/group/nolan/
protocols/pro_helper_dep.html).
Culture of keratinocytes in culture medium conditioned by fibroblasts
Fibroblasts were seeded at a density of 104 cells/cm2 and cultured for 72 hours. Fibroblasts
were then cultured in FAD containing 0.5% FCS and conditioned supernatants were collected
after 48 hours. Keratinocytes were seeded at 11 000 cells/cm² on lethally irradiated 3T3-J2
Swiss mouse fibroblasts in cFAD for 24 hours. Cells were then cultured in FAD containing
0.5% FCS for 24 hours before being incubated in the fibroblasts conditioned media for 72
hours. Keratinocytes were then lysed for RNA and proteins preparations.
Expression of SHH in culture supernatants from either fibroblasts or
fibroblasts and keratinocytes co-cultures
For analyses of SHH secretion by fibroblasts, cells were seeded at 104 cells/cm2 and cultured in
fibroblasts medium for 48 hours. Cells were then incubated in fibroblasts medium without FCS
for 48 hours. For analyses of SHH secretion in fibroblasts-keratinocytes co-cultures, fibroblasts
were first seeded at 104 cells/cm2 in cFAD for 24 hours. Keratinocytes were then added to the
fibroblasts cultures at a density of 7 500 cells/cm2. Co-cultures of fibroblasts and keratinocytes
Fibroblasts in Basal Cell Carcinoma
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were incubated in keratinocyte-SFM medium (Gibco, Life technologies, NY, USA) for 48
hours. Conditioned media were then collected, concentrated on Vivaspin columns (Sartorius
Stedim Biotech GmbH, Goettingen, Germany), and protein extracts were analysed by western
blot. Three independent conditioning experiments were performed.
Organotypic skin cultures
OSC were prepared as described [22]. Briefly, human dermal fibroblasts (passages P5 to P8)
were embedded into a type I bovine collagen gel at a concentration of 2.106 cells/ml. After 4
days of contraction of the dermis equivalent, 5.104 keratinocytes were seeded onto the dermis
equivalent and cultured in immersion for 7 days before being raised at the air-liquid interface
for 7 additional days. When indicated, OSC were processed in the presence of 5 μg/ml of either
the anti-SHH 5E1 monoclonal antibody (mAb) (DHSB, Iowa, IA, USA) or the isotype-
matched anti-cMyc 9E10 mAb (Biomol, Plymouth Meeting, PA, USA). OSC were then pro-
cessed for paraffin inclusion or snap freezing in liquid nitrogen.
Quantitative invasion assay
Organotypic culture system was set up according to Gaggioli [23]. Briefly, 5.105 fibroblasts
were embedded in a mixture of collagen I (#354249; BD Biosciences, Oxford, UK) and Matrigel
(#354234; BD Biosciences). After 1 hour at 37°C, 4.105 keratinocytes were plated on top of the
gels, and incubated overnight at 37°C, 10% CO2. Gels were then mounted at the air-liquid
interface and fed through capillarity diffusion by cFAD culture medium. After 7 days, the cul-
tures were harvested and fixed using 4% paraformaldehyde, 0.25% glutaraldehyde. The inva-
sion index [1 –(non-invading keratinocytes area/invading and non invading cells area)] values
represents the average of 3 total sections from two independent organotypic skin cultures.
Histology and immunostaining
Hematoxylin-Eosin (H&E), immuno labellings on paraffin sections, and indirect immunofluo-
rescence analyses on frozen sections were performed as described [24]. Immunostaining of
Laminin B1, β1 Integrin, and P53 were performed on paraffin sections using rabbit anti-Lami-
nin B1 serum (1/400; Novotec, Paris, France); anti-β1 integrin mAb (1/50; clone 4B7, Onco-
gene Research Products, Boston, MA, USA); P53 monoclonal antibody (1/50; clone DO-7,
Dako, Glustrup, Denmark), respectively. Staining was revealed using appropriate secondary
antibodies linked to alkaline phosphatase and the Envision kit (Dako, Glustrup, Denmark) fol-
lowed by H&E counter-staining. Immunostainings of Keratin 10, Loricrin, and Ki67 were per-
formed on air-dried cryosections using the anti-Keratin 10 mouse mAb (1/10; RKSE 60,
Sanbio, Uden, The Netherlands), anti-Loricrin rabbit antiserum (1/200, [25]) and Ki67 mAb
(1/20, NovoCastra, Newcastle, UK).
Senescence-associated β-galactosidase (SA-β-Gal) activity
Fibroblasts were seeded at a density of 8 500 cells/cm2 in fibroblasts medium for 48 hours.
Fibroblasts were then cultured in FAD medium depleted in calcium and containing 0.5% FCS
and conditioned supernatants were collected after 72 hours. WT keratinocytes (2 000 cells/
cm2), SCC13 cells (2 000 cells/cm2), and WT E6-E7 keratinocytes (650 cells/cm2) were seeded
onto glass coverslips in cFAD for 72 hours. Cells were then cultured in calcium-free FAD
medium containing 0.5% FCS for 24 hours before being incubated in the fibroblasts condi-
tioned media for 48 hours. SA-β-Gal activity in cultured keratinocytes was detected using the
SA-β-Gal staining kit (Cell Signaling Technology, Danvers, MA, USA) according to the
Fibroblasts in Basal Cell Carcinoma
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manufacturer's recommendations. For positive control of SA-β-Gal activity, WT keratinocytes
were treated for 2 hours with 200 μMH2O2. After processing, cells were photographed under
reflected light. The ratio of SA-β-Gal positive cells / total cell numbers was determined by blind
counting of 10 fields / slide by 3 independent experimentators.
Protein extraction and western blotting
For western blot detection of P53, P16, and P21, proteins were solubilized in 8 M Urea lysis
buffer (8 M Urea, 50 mM Tris-HCl, 0.1 M β-Mercaptoethanol, 1 mMDTT, 100 μg/ml phenyl-
methanesulfonylfluoride). Proteins (15 μg) were separated by 8% (P53) or 14% (P21, P16)
SDS-PAGE, blotted onto polyvinyl difluoride (PVDF) membrane (Millipore, Corporation, Bil-
lerica, MA, USA), and revealed using the anti-P53 DO-7 mAb (1/1000; Dako, Glustrup, Den-
mark), the anti-P21 EA10 mAb (0.5 μg/ml; Abcam ab16767, Cambridge, UK), or the anti-
human-P16 mAb (1/1 000, BD Biosciences, Le Pont de Claix, France). Membranes were re
probed using the anti-GAPDHmAb (1/2000; Abcam 9484, Cambridge, UK) or the anti-β-
Tubulin TUB2.1 mAb (1/5 000, Sigma Aldrich, St Louis, MO) for loading/transfer controls.
Membranes were then analysed using the Luminata crescendo western HRP substrate (Milli-
pore Corporation, Billerica, MA, USA). Quantification of P53 was performed using the ImageJ
software. Quantification of P21 and P16 was performed using the Fusion-Capt software (Vilber
Lourmat, Eberhardzell, Germany). For detection of SHH, 1μg of concentrated culture superna-
tants were subjected to 10% SDS-PAGE, blotted, and revealed using the N-SHH 167Ab poly-
clonal antibody [26]. Quantification of N-SHH was performed using GeneGnome device and
GeneTools software (Syngene, Synoptics Ltd, Cambridge, UK).
RNA extraction and quantitative RT-PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen, Hilden, Germany). Reverse tran-
scription was performed from 1 μg RNA using the Superscript II Reverse Transcriptase (Roche
Applied Science, Basel, Switzerland) and random primers. Real Time-PCR was carried out on
cDNAs using primers listed in S2 Table and the 7900 HT Fast Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA). Results were normalized using the GeNorm software
(http://medgen.ugent.be/Bjvdesomp/genorm/). Statistical analysis was performed using the
Mann-Whitney test. Semi-quantitative PCR were performed using PATCHED1 primers F: 50-
GATAAGAGCTCCGGGGGATTC-30 and R: 50-CACAGTAGCTTAGGCTTCAGCCC-30,
and GAPDH primers F: 5’-CCAAGGCTGTGGGCAAGGTCAT-3’ and R: 5’-TGACAAGGTG
CGGCTCCCTAGG-3’ as described [27]. PCR products were quantified after electrophoretic
separation in 2% agarose gel, and SYBR fluorescence scanning (STORM; Molecular Dynamics,
Sunnyvale, CA) using the ImageQuant software (Amersham Biosciences, Amersham, United
Kingdom).
Transcriptional activity of the PATCHED1 gene promoter
Keratinocytes were seeded at a density of 16 000 cells/cm2. Transient transfections were per-
formed as described [27]. The RSV-β-Gal plasmid was used as a control to normalize transfec-
tion efficiency. After transfection, keratinocytes were maintained for 72 hours in medium
conditioned from control or NBCCS fibroblasts and the luciferase and β-Gal enzymes activities
were measured using the luciferase assay system and β-Gal enzyme assay system kits (Promega
Corporation, Madison, WI, USA) [27].
Fibroblasts in Basal Cell Carcinoma
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Reactive oxygen species (ROS)
Accumulation of ROS was examined by using 2’,7’-dichloro-fluorescin diacetate
(CM-DFHDA) (InvitrogenTM/Molecular probes, Eugene, Oregon, USA). Keratinocytes were
seeded at 11 000 cells/cm2 in cFAD for 48 hours. Cells were then incubated in fibroblast-condi-
tioned media for 1 hour and then incubated in CM-DCFHDA in HBSS for 30 min at 37°C.
Cells were then washed, dissociated, and resuspended in HBSS. Fluorescence was recorded at
an excitation/emission wavelength of 485 nm/530 nm by flow cytometry on a FACS Calibur
flow cytometer (BD Biosciences, San Jose, CA, USA).
Statistical analyses
For the box plot representation, the line in the middle of the box represents the median. The
box extends from the 25th percentile to the 75th percentile. The lines emerging from the box extend
to the upper and lower adjacent values. Significance of the differences between experimental values
measured in NBCCS and inWT fibroblasts was assessed using the Mann-Whitney test.
Results
NBCCS fibroblasts impact homeostasis of wild type epidermis
We first analyzed the potential impact of NBCCS primary fibroblasts on epidermal morpho-
genesis using OSC. NBCCS fibroblasts from two independent patients bearing distinct
PATCHED1 nonsense mutations (NBCCS6: c.1925dupC; p.Pro643ThrfsX11 and NBCCS10:
c.1366delA; p.Thr456ProfsX35) were incorporated in a dermis equivalent (PATCHED + /-)
overlaid with a stratified squamous epithelium developed from primary WT keratinocytes
(PATCHED +/+) (NBCCS OSC) and compared to fully WT OSC. Under these circumstances,
the presence of NBCCS fibroblasts in the dermis equivalent was accompanied by a decrease in
the thickness of the epidermis, the absence of bona fide cornified layers and the persistence of
nuclei in the upper suprabasal epidermal layers (parakeratosis) (Fig 1). In addition, the
Fig 1. NBCCS fibroblasts alter morphology and differentiation of WT epidermis.WT keratinocytes were seeded onto dermis equivalents comprising
skin fibroblasts isolated from either a WT (WT1) donor or from two independent NBCCS patients (NBCCS6 and NBCCS10). H&E staining reveals the
absence of cornified layers (CL) and slight epidermal thinning in NBCCSOSC. Note increased accumulation of Laminin B1 and β1 Integrin in the basal layer
(BL) and the para basal layers of epidermis. Star (*) points dermo epidermal cleft between the dermal and the epidermal compartments. Also note delayed
expression of Keratin 10 (K10) and absence of expression of Loricrin (Lor) in NBCCSOSC; PI, nuclei counter staining using propidium iodide. Dash lines
delineate the dermo epidermal junction. Bar: 110 μm
doi:10.1371/journal.pone.0145369.g001
Fibroblasts in Basal Cell Carcinoma
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presence of NBCCS fibroblasts was accompanied by clefts at the dermo-epidermal junction, a
feature of human BCCs [28]. In contrast, fully WT OSC showed bona fide cornified layers and
the absence of such parakeratotic features. Immunolabelling of OSC containing NBCCS fibro-
blasts indicated that deposition of Laminin B1, a major component of the basement membrane,
and of β1 Integrin, a trans-membrane protein essential for the attachment of basal keratino-
cytes to the basement membrane, were increased compared to WT OSC. In addition, β1 Integ-
rin, which is normally limited to keratinocytes located in the basal layer, extended in the first
supra basal cell layers. To confirm the relevance of these results, skin sections from patients
NBCCS6 and NBCCS10 were also submitted to histological analyses and labelled using anti-β1
Integrin and anti-Laminin B1 antibodies. Although no gross histological alteration was
observed, the apparent amount of β1 Integrin and Laminin B1 was found to be either slightly
or more strongly increased in NBCCS, respectively, compared to control skin (S1 Fig).
In NBCCS OSC, labelling of the Keratin 10 (K10), a differentiation marker whose normal
onset of expression occurs in parabasal, post-mitotic epidermal cell layers, was extended to the
second to third rows of epidermal cells (Fig 1). Finally, Loricrin, a precursor of cornified enve-
lopes in terminally differentiated keratinocytes, [25] became barely detectable or even absent in
the presence of NBCCS fibroblasts.
NBCCS fibroblasts provoke stabilisation of P53 in WT keratinocytes
Taken the above data into account, we aimed at measuring the number of cycling epidermal-
keratinocytes positive for Ki-67 labelling in the presence of NBCCS fibroblasts within dermis
equivalents. Surprisingly however, number of Ki-67 positive keratinocytes was about 10 times
lower in the presence of NBCCS fibroblasts than in the presence of WT fibroblasts (Fig 2). To
explore the possible mechanism(s) responsible for the decreased proliferation of WT epidermal
keratinocytes located in the vicinity of NBCCS fibroblasts, we analyzed the expression of the
P53 tumor suppressor protein provided its function as a major effector of cell cycle arrest at
G1-S and G2-M check points [29].
In NBCCS OSC, the number of P53-positive nuclei was enhanced 5.5 to 7.5 times (Fig 2A
and 2B) as compared to WT OSC. These observations indicated that the presence of NBCCS
fibroblasts within the dermis equivalent was sufficient to severely perturb keratinocyte prolifer-
ation as well as the early and subsequent steps of epidermal differentiation. Further, due to the
3D architecture of OSCs, these results suggested to us that NBCCS fibroblasts could perturb
skin homeostasis through diffusible molecules accommodating a dialog between the dermis
and the epidermis.
How NBCCS fibroblasts may alter behavior of epidermal keratinocytes?
Given that NBCCS fibroblasts could impact epidermal homeostasis through diffusible mole-
cules, we assessed in 2D culture conditions expression of secreted proteins as previously
reported in NBCCS fibroblasts cultured in 3D dermis equivalents in the absence of epidermal
keratinocytes [17]. Under these circumstances, a minimal fraction of 9 of the 18 mRNA signa-
ture was differentially expressed (significantly) in WT versus NBCCS fibroblasts (Table 1).
Among these mRNAs, the average levels of the anti-angiogenic proteins angiopoietin-like 4
(ANGPTL4) and matrix GLA protein (MGP) mRNAs were increased by 5.6 (p<0.025) and
61.7 (p<0.05), respectively, in NBCCS compared to WT cells. As well, relative levels of the
C-X-C ligand 12 (CXCL12) and fibroblast growth factor 7 (FGF7) mRNAs were increased in
NBCCS fibroblasts by 4.0 and 2.9 fold, respectively (p<0.025). The WNT/-catenin signaling
pathway is known to be activated in CAFs [30, 31]. In 2D cultures of NBCCS fibroblasts, 4
mRNAs of the WNT/-catenin pathway were found mis-regulated as in 3D dermis equivalents.
Fibroblasts in Basal Cell Carcinoma
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Fig 2. NBCCS fibroblasts alter proliferation of WT keratinocytes in organotypic skin cultures. (A)
Rates of cycling keratinocyte (Ki67, green/yellow nuclei), and P53-positive keratinocytes (P53, brown nuclei)
were blind counted by 3 independent investigators on sections of OSCs, as indicated. Bar: 170 μm. (B) Ki67-
(left panel) and P53- (right panel) positive keratinocytes were counted in the basal layer of 10 different fields
spread along 3 independent sections. Error bars indicate the mean ± SD of the counted fields. (C), Western
blot analysis shows stabilization of P53 in WT keratinocytes (WT1) treated for 24 h in culture supernatants
conditioned by NBCCS (NBCCS6 and NBCCS10) fibroblasts (left panel). Right panel shows levels of P53
relative to GAPDH and expressed as fold induction relative to theWT fibroblasts strain. Error bars indicate
the mean ± SD of triplicate experiments.
doi:10.1371/journal.pone.0145369.g002
Fibroblasts in Basal Cell Carcinoma
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Amount of mRNAs encodingWNT5A (ligand) and Dickkopf 3 (DKK3) (inhibitor) were
decreased by 5.0 and 2.0 (p<0.025), respectively. Amount of mRNAs of the WNT target genes
WISP2 (WNT1 inducible signaling pathway protein 2) and ID2 (inhibitor of DNA binding 2)
were increased by 4.9 (p<0.05) and 3.2 (p<0.025), respectively. As in 3D conditions, levels of
COL7A1mRNA were decreased in NBCCS fibroblasts cultured in 2D conditions compared to
control cells (5.0 fold; p<0.05). In contrast, mRNAs encoding MMPs (1 and 3), COL11A1,
COL3A1, LAMA2, TNC, GREM1, ANGPTL2, and SFRP2 were no longer mis-regulated in
NBCCS fibroblasts cultured in 2D conditions while they were in 3D. These results indicated
that a fraction of transcriptional deregulations previously described in 3D NBCCS dermis
equivalents are conserved under 2D culture conditions, hence allowing fibroblast-led condi-
tioning experiments of epidermal keratinocytes.
NBCCS fibroblasts alter keratinocytes behavior through diffusible
molecules
Whether diffusible factors expressed by NBCCS fibroblasts could act on stabilization of P53 in
epidermal cells was assessed by treating WT keratinocytes with culture supernatants condi-
tioned by either WT or NBCCS fibroblasts. Western blot analyses showed that levels of P53
were slightly increased in WT keratinocytes treated with culture supernatants of NBCCS fibro-
blasts (Fig 2C). These observations strongly suggested that NBCCS fibroblasts secrete mole-
cules leading to P53 stabilization and cell cycle modifications in WT keratinocytes. Among the
identified factors showing altered expression in NBCCS fibroblasts, ANGPTL4 has been shown
to elevate the intracellular O2:H202 ratio in a manner dependent of β-1 and β-4 Integrins and
Table 1. AveragemRNA expression levels in WT or NBCCS fibroblasts in either 2D or 3D cultures conditions.
Genes Name 2D 3D
Average NBCCS / average WT NBCCS <or> WT p-value Average NBCCS / average WT NBCCS <or> WT p-value
MMP1 12.1 NS 8.4 p<0.025
MMP3 4.1 NS 26.8 p<0.025
COL3A1 0.8 NS 0.7 p<0.05
COL7A1 0.3 p<0.025 0.6 p<0.05
COL11A1 7.2 NS 11.5 NS
LAMA2 1.0 NS 0.4 p<0.025
TNC 0.5 NS 1.2 NS
CXCL12 4.0 p<0.025 2.4 p<0.025
MGP 61.7 p<0.05 5.2 p<0.025
ANGPTL2 1.7 NS 3.0 p<0.025
ANGPTL4 5.6 p<0.025 9.8 p<0.025
FGF7 2.9 p<0.025 2.3 p<0.05
GREM1 1.6 NS 1.7 NS
SFRP2 0.7 NS 3.5 p<0.025
DKK3 0.5 p<0.025 0.3 p<0.025
WNT5A 0.2 p<0.025 0.5 p<0.05
WISP2 4.9 p<0.05 2.7 p<0.05
ID2 3.2 p<0.025 2.6 p<0.025
The level of mRNA of the indicated genes was measured by RT-qPCR on the mRNAs extracted from cultures of ﬁbroblasts in 2D conditions or from
dermal equivalents (3D) (WT: n = 3; NBCCS: n = 6). The ratio between the average mRNA levels in the NBCCS and the WT ﬁbroblasts and the p-value
are indicated. NS: not signiﬁcant (p>0.05).
doi:10.1371/journal.pone.0145369.t001
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to confer anoikis resistance to tumors cells [32]. Based on these observations, we assessed
whether overexpression of ANGPL4 in NBCCS fibroblasts could provoke a paracrine stress in
epidermal keratinocytes, hence leading to P53 stabilization. However, quantifications of reac-
tive oxygen species (ROS) in WT keratinocytes conditioned in either primary WT or NBCCS
fibroblasts culture supernatants, failed to reveal any difference among our experimental set-
tings (S2 Fig). Finally, in spite of a slight increase of P53 stabilization in WT keratinocytes cul-
tured in medium conditioned by WT or NBCCS fibroblasts, we failed to detect any significant
variation in cell cycle features (not shown). Consistently, the check point protein P21, a canoni-
cal target of P53, was not increased (but even rather slightly decreased) under our experimental
conditions, suggesting that stabilization of P53 in 2-D cultures was not sufficient to provoke
significant cell cycle alterations, such as accumulation of keratinocytes in G1 or sub-G1 phases.
Then we hypothesized that NBCCS fibroblasts could alter the behavior of epidermal kerati-
nocytes through a senescent-like mechanism. We measured the accumulation of SA-β-Gal) in
keratinocytes with different genetic backgrounds treated with culture supernatants conditioned
by WT or NBCCS fibroblasts (Fig 3). Culture supernatants conditioned by NBCCS6 and
NBCCS10 fibroblasts induced an increase in the number of SA-β-Gal positive cells in WT1 ker-
atinocytes (1.55-fold and 2.29-fold increases, respectively). In contrast, we did not observe any
increase of SA-β-Gal in keratinocytes with P53 altered genetic backgrounds, i.e. in both WT1
E6-E7 or SCC13 keratinocytes.
On the base of the increase of SA-β-Gal in WT keratinocytes conditioned in culture super-
natants of NBCCS fibroblasts, we next investigated the role of P21 and P16, two cell-cycle
check point regulators that expressions have been described in senescent cells [33]. Surpris-
ingly, however, western blots indicated a marked decrease of P21 and P16 proteins in WT kera-
tinocytes cultured in media conditioned by NBCCS fibroblasts (S3 Fig). These results suggest
that the increase of the SA-β-Gal activity described above is not correlated with stabilization of
the P21- and P16 check point proteins.
NBCCS fibroblasts impact the SHH/PATCHED pathway in WT
keratinocytes
Numerous researches have shown that SHH production could be misregulated in various can-
cer types, notably those involving alteration of mesenchyme / stromal cells [34]. Expression of
SHH was thus analyzed in NBCCS and WT fibroblasts and in keratinocytes cultured in 2D.
RT-qPCR analysis indicated the absence of SHHmRNA in keratinocytes and hardly detectable
expression in fibroblasts (not shown). In neither WT nor NBCCS fibroblast culture superna-
tants, the active N-terminal fragment of SHH (N-SHH), could be detected by western blot
analyses (Fig 4). In contrast, N-SHH became detectable in culture media obtained after 48
hours of co-cultures of WT keratinocytes with WT fibroblasts (Fig 4B). Secretion of N-SHH
was further increased in co-cultures of WT keratinocytes with NBCCS fibroblasts (from x 1.8
to x 2.4).
Since PATCHED1 is a transcriptional target of the SHH/PATCHED pathway, WT keratino-
cytes were then conditioned with culture supernatants of NBCCS fibroblasts and levels of
PATCHED1mRNA in keratinocytes were measured by RT-qPCR. In parallel, WT keratino-
cytes were transfected with a vector bearing the 4,4 kb 5’ regulatory region of the human
PATCHED1 gene upstream the firefly luciferase reporter gene [27] and cultured in the medium
conditioned by NBCCS fibroblasts. Fig 5 indicates that both approaches resulted in a 20–30%
increase of PATCHED1mRNA amount and transcription. These observation were relevant of
a modest but reproducible activation of the SHH pathway in WT keratinocytes exposed to cul-
ture supernatants conditioned by NBCCS fibroblasts.
Fibroblasts in Basal Cell Carcinoma
PLOSONE | DOI:10.1371/journal.pone.0145369 December 22, 2015 10 / 21
Fig 3. Culture supernatants from NBCCS fibroblasts promote SA-β-Gal activity in WT but not in transformed (E6-E7) or tumoral (SCC13)
keratinocytes. (A) SA-β-Gal activity in WT1, WT1 E6-E7, and SCC13 keratinocytes after treatment with either non conditioned medium (NCM), culture
supernatant conditioned byWT (WT1), or NBCCS (NBCCS6 and NBCCS10) fibroblasts. (B) SA-β-Gal positive cells were blind counted by three independent
investigators. Bars represent the confidence intervals (α = 0.05). Number of SA-β-Gal positive cells was increased in WT keratinocytes treated with NBCCS
supernatants. No increase of SA-β-Gal positive cells was detected in both WT1 E6-E7 and SCC13 keratinocytes.
doi:10.1371/journal.pone.0145369.g003
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To assess whether SHH secretion by NBCCS dermal fibroblasts could be implicated in epi-
dermal alterations, OSC were developed in the absence or in the presence of the 5E1 anti-SHH
blocking antibody. Fig 6 shows that treatment of OSC with the 5E1 blocking antibody (but not
an isotype-matched monoclonal antibody) minimized epidermal perturbations observed in the
presence of NBCCS fibroblasts. H&E staining revealed increased thickness of the epidermis in
NBCCS OSC treated with the blocking 5E1 antibody. Furthermore, labelling of β1 Integrin was
normalized to the basal cell layer in the presence of the blocking 5E1 antibody. These data sup-
port our observations suggesting that the presence of NBCCS fibroblasts leads to a misactiva-
tion of the SHH/PATCHED pathway in the epidermal compartment, and hence, to severe
alterations of the behaviour of epidermal keratinocytes.
Fig 4. SHH secretion depends on the presence of both fibroblasts and keratinocytes and is further
increased in the presence of NBCCS fibroblasts. (A), Western blot analysis of N-SHH secreted from either
WT (WT1) or NBCCS (NBCCS6 or NBCCS10) fibroblasts. Secretion of N-SHH was not detectable in culture
supernatants of WT and NBCCS fibroblasts. (B), Western blot analysis of N-SHH secreted from co-cultures
of WT keratinocytes with WT (WT1) or NBCCS fibroblasts (NBCCS6 or NBCCS10). N-SHH became slightly
detectable in the presence of WT fibroblasts (WT1). N-SHH amount was substantially increased in the
presence of NBCCS fibroblasts (NBCCS6, NBCC10). Lower panel: quantitation of N-SHH in culture
supernatant obtained under the circumstances described for the upper panel. Note that detection of SHH is
limited to the N-SHH processed protein (22 kDa, arrow).
doi:10.1371/journal.pone.0145369.g004
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NBCCS fibroblasts confer invasiveness of keratinocytes with abrogated
P53
Although our data showed that P53 is stabilized in keratinocytes in OSC comprising a NBCCS
dermis equivalent or after their incubation in culture supernatants conditioned by NBCCS
fibroblasts, we failed to identify the exact nature of such a stress. However, since most skin
tumors harbor P53 deleterious mutations (IARC TP53 database, R17 November 2013, www.
p53.iarc.fr), [35] we aimed at measuring the impact of P53 abrogation in WT and NBCCS kera-
tinocytes exposed to NBCCS fibroblasts in organotypic invasion assays. To do so, NBCCS
Fig 5. NBCCS fibroblasts stimulate PATCHED1 transcription in WT keratinocytes. (A), PATCHED1 and
GAPDHmRNAs amounts expressed byWT keratinocytes cultured with either WT or NBCCS fibroblasts
(NBCCS6 or NBCCS10) were determined after semi-quantitative PCR and agarose gel electrophoresis
(upper panel). Relative PATCHED1mRNA levels were increased in WT keratinocytes (WT1) treated with
culture media derived from NBCCS fibroblasts (NBCCS6 and NBCCS10) (lower panel). (B), Activity of the
PATCHED1 promoter in WT keratinocytes cultured in media conditioned from either WT or NBCCS
fibroblasts (NBCCS6 or NBCCS10). Note the substantial increase of the relative transcriptional activity of the
PATCHED1 promoter in WT keratinocytes treated with culture media conditioned by NBCCS fibroblasts.
Experiments were performed two times in triplicates, p<0.09.
doi:10.1371/journal.pone.0145369.g005
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primary keratinocytes were transduced using retroviral vectors allowing expression of the
HPV16 E6-E7 protein, and hence the ubiquitination and proteasome degradation of P53 (Fig
7A). Under these circumstances, both WT E6-E7 and NBCCS E6-E7 keratinocytes became
invasive in the presence of NBCCS fibroblasts (Fig 7B and 7C, S4 Fig). Since expression of the
HPV16 E6 and E7 oncoproteins not only abrogates expression of P53 but also of the Retino-
blastoma 1 protein (Rb1), we also introduced human keratinocytes isolated from human squa-
mous cell carcinoma as a control (SCC13 [36]). Alike WT keratinocytes transformed by the E6
E7 oncoproteins, SCC13 cells became highly invasive in organotypic skin cultures containing
NBCSS but not WT fibroblasts (not shown). These observations argue in favor of a central
role of P53 in counteracting alterations of the dermo epidermal dialog led in the presence of
NBCCS fibroblasts.
Discussion
BCCs are skin cancers that exceptionally metastasize but may present with a high potential of
local invasiveness. Since the early 60s, [37, 38] it has been hypothesized that growth of BCC
cells depends on specific micro environmental conditions. This notion is further supported by
the fact that in contrast to SCC cells, [36] BCC cells cannot be propagated ex vivo. Here, we
present experimental evidences showing that dermal fibroblasts isolated from non-involved
Fig 6. Neutralizing SHH in organotypic skin cultures attenuates alterations of WT epidermis in the presence of NBCCS fibroblasts.OSC comprising
either WT (WT1) or NBCCS fibroblasts (NBCCS6 or NBCCS10) were developed in the presence of either the 5E1 anti-SHH blocking mAb (5E1 mAb) or an
isotype-matched (anti-Myc 9E10) control antibody (Control mAb). OSC sections were stained with either H&E, or immunolabeled with the anti-β1 Integrin
mAb. Note that developing OSC in the presence of the 5E1 antibody improved epidermal atrophy (as pointed out by black arrows) and β1 Integrin
delocalization otherwise observed in the presence of NBCCS fibroblasts. Bar: 110 μm
doi:10.1371/journal.pone.0145369.g006
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Fig 7. Abrogation of P53 in NBCCS keratinocytes confers invasive properties in the presence of NBCCS fibroblasts. (A) Western blot analysis of P53
showed a strong attenuation in WT (WT1), NBCCS6 and NBCCS10 keratinocytes transduced with a retrovirus expressing the HPV16 E6 and E7
oncoproteins. (B) Representative images of H&E coloration of paraffin-embedded sections of organotypic invasion assays composed of either WT E6-E7 or
NBCCS E6-E7 keratinocytes overlaying a dermis equivalent comprising either WT or NBCCS fibroblasts. Bar: 200 μm. (C) Invasion index of keratinocytes
from assays as in (B). Values represent the average of 3 total sections from two independent organotypic cultures. Bars represent the confidence intervals,
α = 0.05.
doi:10.1371/journal.pone.0145369.g007
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non photo-exposed skin biopsies from NBCCS patients severely impact behavior of WT kerati-
nocytes in OSC. Most importantly, our data indicated that the presence of primary NBCCS
dermal fibroblasts in dermis equivalents resulted in P53 stabilization and cell cycle perturba-
tions, a situation reminiscent of keratinocytes response toward genotoxic stress.
In a previous study we showed that primary NBCCS fibroblasts expressed ex vivo and, in a
cell autonomous manner (i.e. in absence of keratinocytes), a transcriptional signature of 18
genes [17] closely similar to that reported in fibroblasts associated to human BCCs [18].
Importantly, a portion of this signature was conserved irrespective of the 2D or 3D culture con-
ditions, suggesting that PATCHED1 heterozygosity constitutively impacts gene expression in
NBCCS fibroblasts. The transcriptional signature of NBCCS fibroblasts included genes associ-
ated with tumor cell invasion, metastasis, and neoangiogenesis. Notably, NBCCS fibroblasts
expressed higher mRNA levels of the anti-angiogenic protein ANGPTL4 which is known to
limit tumor cell motility and invasiveness [39] and the invasive potential of BCC cells, as well
[40, 41]. Also, we noticed an important decrease of COL7A1mRNA in NBCCS primary fibro-
blasts. Deleterious mutations of COL7A1 have been associated with the development of aggres-
sive SCCs in patients suffering from the recessive Hallopeau-Siemens dystrophic epidermolysis
syndrome (HS-RDEB) [42] while its restoration delayed tumor cell dissemination in vitro and
in vivo [43]. In HS-RDEB fibroblasts, abrogation of COL7A1 expression has also been shown
associated with increased levels ofWNT5AmRNAs [43].WNT5A expression was also found
augmented in vivo, in the stroma from pancreas cancers [31] and in fibroblasts surrounding
both cutaneous SCC and BCC cells [44]. In spite of these observations, NBCCS fibroblasts
exhibited decreased levels ofWNT5AmRNAs, while, paradoxically, some markers of the acti-
vation of the WNT pathway (WISP2 and ID2mRNAs) where found increased. The mecha-
nisms by which heterozygosity of PATCHED1 in NBCCS primary fibroblasts orchestrate the
interplay between the SHH andWNT pathways then deserves further research.
Experiments in transgenic mice have shown that development and maintenance of BCC-
like lesions depend on either ectopic and sustained secretion of SHH in the basal germinative
epidermal keratinocytes, [45, 46] or from overexpression of GLI1 [47] or of GLI2 [48]. Our
results in human cells indicated that SHHmRNAs were undetectable in keratinocytes and
barely detectable in fibroblasts cultures. Surprisingly enough, and for the first time, cultures of
WT keratinocytes with WT fibroblasts resulted in detectable SHH secretion. The amount of
secreted SHH was further increased in co-cultures of WT keratinocytes and NBCCS fibro-
blasts. These results strongly suggested that NBCCS fibroblasts play a key role in the regulation
of the SHH/PATCHED pathway in epidermal keratinocytes. In good agreement with these
results, we showed that expression of endogenous PATCHED1mRNA and the activity of the 5’
regulatory region of the PATCHED1 gene were slightly but reproducibly increased in WT kera-
tinocytes maintained in the presence of culture supernatants conditioned by NBCCS fibro-
blasts. Ectopic expression of SHH in murine basal keratinocytes has been suggested to result in
increased proliferation and tumor development [11]. Together with clinical observations show-
ing that NBCCS BBCs may occur in non photo-exposed skin areas, these observations suggest
that NBCCS fibroblasts could play a decisive role in the onset of BCCs. It is very important to
notice that, due to the failure to grow BCC cells in culture, we could not assess the impact of
NBCCS fibroblasts on BCC cells behavior under in vivo settings, i.e. using mouse as a vector of
BCCs development.
In addition to these observations, OSC composed of NBCCS fibroblasts and WT keratino-
cytes exhibited abnormal traits of epidermal stratification and differentiation with thinning of
the epidermal compartment. The presence of NBCCS fibroblasts also resulted in the formation
of dermo-epidermal clefts, a feature commonly found at the periphery of human BCC in vivo,
[28, 49] but not described in non-lesional skin from NBCCS patients [5]. It is conceivable that
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dermo-epidermal clefts found in OSC were to be connected to our observations showing accu-
mulation of MMP1 and MMP3 mRNAs in NBCCS primary fibroblasts [17].
In addition to epidermal thinning and dermo-epidermal clefting, severe alterations of the
stepwise program of epidermal differentiation were noticed. β1 Integrin was extended to the
suprabasal epidermal layers, where it is generally low or undetectable, while K10 Keratin was
found delayed (K10) and Loricrin severely decreased (Loricrin) in the presence of NBCCS
fibroblasts. Morphological defects and terminal differentiation were then partly normalized in
the presence of the SHH-blocking antibody 5E1, further supporting the idea that over secretion
of SHH by NBCCS dermal fibroblasts in the presence of WT keratinocytes may affect epider-
mal homeostasis. Traits of delayed differentiation in sporadic skin tumors or in psoriasis skin
lesions [50] are usually associated with hyper proliferation. Unexpectedly however, in spite of
delayed epidermal differentiation, we observed a sharp decrease of Ki67-positive keratinocytes
overlaying NBCCS fibroblasts, indicating that NBCCS fibroblasts alter proliferation of WT ker-
atinocytes. Together with decreased numbers of Ki67-positive cells, the P53 protein was found
stabilized in epidermal cells either overlaying a NBCCS dermis equivalent or following incuba-
tion in culture supernatants of NBCCS fibroblasts. In spite of P53 stabilization, no sign of apo-
ptosis was detected in sections of OSC containing NBCCS fibroblasts (not shown). In addition,
in 2D culture conditions, we failed to detect any increase in the stabilisation of P21 which is a
direct transcriptional target of P53. These observations suggest that although they promote
P53 stabilization in WT keratinocytes, culture supernatants of NBCCS fibroblasts are not able
to activate the P21 checkpoint in 2D culture conditions, and/or in the absence of a fibroblast-
keratinocyte dialog, as observed for N-SHH (over)expression (in NBCCS fibroblasts). Since
stabilization of P53 results from exposure to genotoxic stresses [29] including ROS, [51, 52] we
hypothesized that NBCCS fibroblasts could be responsible for such a stress in keratinocytes.
Under our experimental settings, no ROS accumulation could be detected in WT keratinocytes
treated with culture supernatants conditioned by NBCCS fibroblasts. However, in the frame of
the same experimental design, WT keratinocytes cultured in NBCCS fibroblasts conditioned
medium exhibited substantial increase of SA-β-Gal activity. In spite of this, neither the P16 nor
the P21 markers of senescence [53] were stabilized under our experimental conditions, but
rather appeared in reduced amounts. Further analyses should indicate whether NBCCS fibro-
blasts provoke an atypical mechanism of senescence irrespective of 2D or 3D cell culture condi-
tions, or, alternatively, that triggering of a bona fide senescent mechanism depends on the
presence of keratinocytes (in 3D organotypic skin cultures).
The mechanism by which secretory components from NBCCS fibroblasts can affect expres-
sion of gatekeeper proteins such as P53 in keratinocytes deserves further investigations. Never-
theless, we observed that strong attenuation of P53 expression in keratinocytes immortalized
by the oncogenic HPV-16 E6-E7 proteins elicited epidermal invasions in the presence of
NBCCS fibroblasts. Altogether, these observations suggested that fibroblasts-led stabilization
of P53 in keratinocytes ensues from a yet unidentified genotoxic stress. In NBCCS patients,
dermal fibroblasts could thus further promote the development of numerous BCCs before or
after abrogation of P53 following an environmental mutagenic stress, as reported in more 50%
skin cancers.
In conclusion, our observations further document the role of the SHH/PATCHED pathway
in cutaneous homeostasis in the human. We propose that susceptibility of NBCCS patients
towards BCCs could be partly due to a “pre activated state” of stromal fibroblasts. Normalizing
fibroblasts “pre activation” using appropriate pharmacological substances could improve the
high susceptibility of NBCCS patients toward BCCs development and, presumably, of human
cancers associated to unbalanced SHH/PATCHED pathway.
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Supporting Information
S1 Fig. Alteration of early markers of epidermal differentiation in NBCCS skins in vivo.
Paraffin sections of non photo-exposed skin fromWT (WT1), NBCCS6 and NBCCS10
patients were subjected to immunolabelling for Laminin B1 and β1 Integrin, as indicated. Note
the increased deposition of both β1 Integrin and Laminin B1 as observed in OSC containing
NBCCS fibroblasts. Bar: 100 μm.
(TIF)
S2 Fig. Effects of NBCCS culture supernatant on ROS production in WT keratinocytes.
The accumulation of ROS in WT keratinocytes was measured using the fluorescent dye
DCFH-DA and FACS analysis. Upper panels, WT keratinocytes without treatment (Control).
WT keratinocytes treated with non-conditioned fibroblast medium (NCM) or non-condi-
tioned fibroblast medium + H202 (NCM + H202) as positive control of induced-ROS produc-
tion. Lower panels, WT keratinocytes treated with culture media conditioned by either WT
(WT1) or NBCCS (NBCCS6, NBCCS10) fibroblasts. Pre-treatment of WT keratinocytes with
NBCCS culture supernatants did not led to detectable increase of ROS production.
(TIF)
S3 Fig. Effect of NBCCS culture supernatants on P21 and P16 proteins expression in WT
andWT E6-E7 keratinocytes.Western blot analysis showed decreased expression of P16 and
P21 in WT keratinocytes treated with culture supernatants conditioned by NBCCS fibroblasts.
P16 was also decreased in WT1 E6-E7 cells. P21 was not expressed in WT1 E6-E7 keratino-
cytes. Right panels show levels of P21 and P16 relative to Tubulin and expressed as fold induc-
tion relative to the WT fibroblast strain.
(TIF)
S4 Fig. Full sections organotypic invasion assays. Images were taken all along the length of
the organotypic sections and assembled using Image Composite Editor (ICE) software.
(TIF)
S1 Table. Patients and cells characteristics.
(DOCX)
S2 Table. Specific TaqMan1 primers used for quantitative real-time PCR analysis.
(DOC)
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